Search
                    Utah Paid Clinical Trials
A listing of 1209  clinical trials  in Utah  actively recruiting volunteers for paid trials and research studies in various therapeutic areas.
            1177 - 1188 of 1209
        
                Utah is currently home to 1209 active clinical trials, seeking participants for engagement in research studies. These trials take place at a variety of cities in the state, including Salt Lake City, Murray, Ogden and West Jordan. Whether you're a healthy volunteer interested in paid medical research or someone seeking trials related to a specific condition, the state offers a diverse array of opportunities in your vicinity.
            
                                                Featured Trial
                
                Healthy Participants Needed (Colonoscopy + Cancer Screening)
            
        Recruiting
            
        Earn $325 - $475 in electronic payment card compensation for your time and effort by participating in a clinical study to develop a blood test that may one day help screen for colon cancer. Take a quick quiz to see if you qualify.
    
    
                            Conditions: 
                                    
        
            
                        Healthy
                    
                                    
                        Healthy Volunteers
                    
                                    
                        Healthy Subjects
                    
                                    
                        Healthy Volunteer
                    
                                    
                        Healthy Participants
                    
                                    Featured Offer
                
                Lose Weight with GLP-1 Medications
            
        Recruiting
            
        Policy Lab has partnered with OnlineSemaglutide.org to offer trusted access to semaglutide and other GLP-1 medications, including generic alternatives to Ozempic® and Wegovy®. 
GLP-1 medications are scientifically backed to help individuals achieve significant weight loss—on average, 15-20% of body weight within a year.
As a valued user, you’re eligible for $50 off your first program with code policy-lab-50.
    GLP-1 medications are scientifically backed to help individuals achieve significant weight loss—on average, 15-20% of body weight within a year.
As a valued user, you’re eligible for $50 off your first program with code policy-lab-50.
                            Conditions: 
                                    
        
            
                        Overweight
                    
                                    
                        Overweight and Obesity
                    
                                    
                        Obesity
                    
                                    
                        Weight Loss
                    
                                    
                        Morbid Obesity
                    
                                    Featured Trial
                
                Stroke Clinical Study
            
        Recruiting
            
        A clinical study for people that suffer with Stroke
    
    
                            Conditions: 
                                    
        
            
                        Stroke
                    
                                    Featured Trial
                
                Chronic Kidney Disease (CKD) Clinical Study
            
        Recruiting
            
        A clinical study for people that suffer with Chronic Kidney Disease (CKD)
    
    
                            Conditions: 
                                    
        
            
                        Chronic Kidney Disease (CKD)
                    
                                    Featured Trial
                
                Ischemic heart disease (IHD) Clinical Study
            
        Recruiting
            
        A clinical study for people that suffer with Ischemic heart disease (IHD)
    
    
                            Conditions: 
                                    
        
            
                        Ischemic heart disease (IHD)
                    
                                    
                
                                    Comparative Pharmacokinetic Study of Three Abatacept Products in Male Normal Healthy Volunteers by the Subcutaneous Route
                                
            
            
        Recruiting
                            
            
                This is a randomised, double-blind, single dose, parallel groups study to compare the PK, immunogenicity, and safety of 3 abatacept products (DRL_AB, RP and RMP) in male NHV.             
        
        
    Gender:
                MALE
            Ages:
                Between 18 years and 50 years
            Trial Updated:
                11/08/2023
            
            Locations: ICON, Salt Lake City, Utah         
        
        
            Conditions: Rheumatoid Arthritis
        
            
        
    
                
                                    Caloric Restriction and Activity to Reduce Chemoresistance in B-ALL
                                
            
            
        Recruiting
                            
            
                This study is for older children, adolescents, and young adults with B-cell Acute Lymphoblastic Leukemia (B-ALL). Higher amounts of body fat is associated with resistance to chemotherapy in patients with B-ALL. Chemotherapy during the first month causes large gains in body fat in most people, even those who start chemotherapy at a healthy weight.
This study is being done to find out if caloric restriction achieved by a personalized nutritional menu and exercise plan during routine chemotherapy...  Read More             
        
        
    Gender:
                ALL
            Ages:
                Between 10 years and 25 years
            Trial Updated:
                10/25/2023
            
            Locations: Primary Children's Hospital, Salt Lake City, Utah         
        
        
            Conditions: B-cell Acute Lymphoblastic Leukemia, Obesity
        
            
        
    
                
                                    Biological Sex and CTEPH-related RV Dysfunction and Recovery (BIOSPHeRe)
                                
            
            
        Recruiting
                            
            
                1. To identify biological sex differences in baseline RV function in CTEPH
2. To identify biological sex differences in recovery of RV function after PTE surgery in CTEPH
3. To determine if sex hormone levels relate to RV function at CTEPH diagnosis and during recovery after PTE.             
        
        
    Gender:
                ALL
            Ages:
                18 years and above
            Trial Updated:
                10/23/2023
            
            Locations: Intermountain Medical Center, Murray, Utah         
        
        
            Conditions: CTEPH
        
            
        
    
                
                                    An ACT Website for College Students With Insomnia
                                
            
            
        Recruiting
                            
            
                College students experience higher rates of insomnia compared the general population, and accessibility and availability for the appropriate intervention is difficult due limited resources available to them in a college environment. Theorefore, it is vital to offer an intervention that can be just as effective yet more accessible than other available treatments targeting insomnia. That is why this study will investigate the efficacy and feasibility of an online ACT intervention for insomnia amon...  Read More             
        
        
    Gender:
                ALL
            Ages:
                18 years and above
            Trial Updated:
                10/20/2023
            
            Locations: Utah State University, Logan, Utah         
        
        
            Conditions: Insomnia
        
            
        
    
                
                                    Smart Ankle-Foot Orthosis to Improve Stroke Outcomes: Smart AFO
                                
            
            
        Recruiting
                            
            
                The Smart Ankle-Foot Orthosis (Smart AFO) system is an investigational system that combines a diagnostic ankle-foot orthosis with a mobile application to assist clinicians in optimizing an AFO user's gait by adjusting AFO stiffness and range of motion settings, and quantifying functional walking improvements in post-stroke individuals. The purpose of the clinical testing is to evaluate the Smart AFO system with its target users: post-stroke AFO users and orthotists. This may include, but is not...  Read More             
        
        
    Gender:
                ALL
            Ages:
                18 years and above
            Trial Updated:
                10/06/2023
            
            Locations: University of Utah, Salt Lake City, Utah         
        
        
            Conditions: Stroke
        
            
        
    
                
                                    A Study to Evaluate the Safety, Tolerability, and Exploratory Efficacy of IMS001 in Subjects With Multiple Sclerosis
                                
            
            
        Recruiting
                            
            
                This is a Phase 1 study of IMS001, given as a single dose to subjects with Multiple Sclerosis who experience inadequate response and/or intolerability to disease modifying treatments. IMS001 is a human embryonic cell derived (hESC) mesenchymal stem cell (MSC). MSCs have the potential to modulate disease course.             
        
        
    Gender:
                ALL
            Ages:
                Between 18 years and 65 years
            Trial Updated:
                09/26/2023
            
            Locations: Rocky Mountain MS Clinic, Salt Lake City, Utah         
        
        
            Conditions: Multiple Sclerosis
        
            
        
    
                
                                    ACT and CBT Bibliotherapy for Perfectionism
                                
            
            
        Recruiting
                            
            
                The goal of this clinical trial is to test self-help books for adults with perfectionism. The main questions it aims to answer are:
1. Are the self-help books (ACT and CBT) effective, compared to a waitlist control condition?
2. What are the processes of change for perfectionism in ACT vs. CBT bibliotherapy?
3. Do the self-help books (ACT and CBT) affect change in general distress, well-being, and affect?
4. Is bibliotherapy an acceptable and feasible intervention for perfectionism?
Participan...  Read More             
        
        
    Gender:
                ALL
            Ages:
                18 years and above
            Trial Updated:
                09/25/2023
            
            Locations: Utah State University, Logan, Utah         
        
        
            Conditions: Perfectionism
        
            
        
    
                
                                    Improving Myoelectric Prosthetic and Orthotic Limb Control
                                
            
            
        Recruiting
                            
            
                The purpose of this study is to improve control of myoelectrically-controlled advanced orthotic devices (an exoskeleton device that use the body's muscle signals to drive movements of a robotic brace) by using advanced predictive decode algorithms, and the use of high count (\> 8) surface electromyographic (sEMG) electrodes.             
        
        
    Gender:
                ALL
            Ages:
                Between 18 years and 70 years
            Trial Updated:
                09/21/2023
            
            Locations: University of Utah, Salt Lake City, Utah         
        
        
            Conditions: Hemiparesis
        
            
        
    
                
                                    JAB-21822 Activity in Adult Patients With Advanced Solid Tumors Harboring KRAS G12C Mutation
                                
            
            
        Recruiting
                            
            
                This study is to evaluate the safety and tolerability of JAB-21822 monotherapy and combination therapy in adult participants with advanced solid tumors harboring KRAS G12C mutation.             
        
        
    Gender:
                ALL
            Ages:
                18 years and above
            Trial Updated:
                09/06/2023
            
            Locations: University of Utah, Salt Lake City, Utah         
        
        
            Conditions: Advanced Solid Tumor, NSCLC, CRC
        
            
        
    
                
                                    Diode Laser as a Biomarker for Neuropathic Pain of Peripheral Origin.
                                
            
            
        Recruiting
                            
            
                The R61 will perform a four-part double-blind randomized crossover study transitioning from a pretreatment baseline phase, to randomized treatment with either lidocaine or an identical placebo patch, washout, and alternate arm. DLss measures will be obtained before and after each phase. Twice daily report of pain using a visual analogue scale will track severity of ongoing spontaneous pain in participants. The hybrid biomarker will distinguish between placebo and active treatment arms, will sign...  Read More             
        
        
    Gender:
                ALL
            Ages:
                Between 18 years and 69 years
            Trial Updated:
                09/05/2023
            
            Locations: University of Utah, Salt Lake City, Utah         
        
        
            Conditions: Peripheral Neuropathy
        
            
        
    
                
                                    A Phase 3 Study to Investigate the Efficacy and Safety of SHR0302 With Moderately to Severely Active Ulcerative Colitis
                                
            
            
        Recruiting
                            
            
                This is a randomized, double-blind, placebo-controlled, multicenter Phase 3 study that will enroll approximately 368 subjects aged 18 to 75 years old with Moderately to Severely Active Ulcerative Colitis.             
        
        
    Gender:
                ALL
            Ages:
                Between 18 years and 75 years
            Trial Updated:
                09/01/2023
            
            Locations: University of Utah, Salt Lake City, Utah         
        
        
            Conditions: Ulcerative Colitis
        
            
        
    
                
                                    Congenital Heart Disease GEnetic NEtwork Study (CHD GENES)
                                
            
            
        Recruiting
                            
            
                Congenital heart defects (CHD) are the most common major human birth malformation, affecting \~8 per 1,000 live births. CHD are associated with significant morbidity and mortality, and are second only to infectious diseases in contributing to the infant mortality rate. Current understanding of the etiology of pediatric cardiovascular disorders is limited.
The Congenital Heart Disease GEnetic NEtwork Study (CHD GENES) is a multi-center, prospective observational cohort study. Participants will b...  Read More             
        
        
    Gender:
                ALL
            Ages:
                99 years and below
            Trial Updated:
                08/29/2023
            
            Locations: University of Utah, Salt Lake City, Utah         
        
        
            Conditions: Congenital Heart Defects
        
            
        
    